Advertisement
Canada markets open in 24 minutes
  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CAD/USD

    0.7316
    -0.0005 (-0.07%)
     
  • CRUDE OIL

    78.04
    -0.44 (-0.56%)
     
  • Bitcoin CAD

    86,955.26
    +12.62 (+0.01%)
     
  • CMC Crypto 200

    1,320.98
    -44.14 (-3.23%)
     
  • GOLD FUTURES

    2,323.40
    -7.80 (-0.33%)
     
  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     
  • 10-Yr Bond

    4.4570
    -0.0320 (-0.71%)
     
  • NASDAQ futures

    18,187.25
    -8.25 (-0.05%)
     
  • VOLATILITY

    13.47
    -0.02 (-0.15%)
     
  • FTSE

    8,309.77
    +96.28 (+1.17%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6785
    -0.0007 (-0.10%)
     

Company News For Jun 25, 2018

WF vs. BEN: Which Stock Is the Better Value Option?
  • Red Hat Inc.’s RHT shares plunged 14.2% after posting fiscal second-quarter 2018 adjusted earnings per share guidance of $0.81 lagging the Zacks Consensus Estimate of $0.88

  • BlackBerry Ltd. BB plummeted 8.7% after reporting fiscal first-quarter 2019 revenues of $217 million, down from year-over-year’s figure of $249 million

  • CarMax Inc.’s KMX shares jumped 12.9% after posting fiscal first-quarter 2019 adjusted earnings per share of $1.33 outpacing the Zacks Consensus Estimate of $1.21

  • Shares of Tandem Diabetes Care Inc. TNDM surged 14% after the company received Food and Drug Administration (FDA) approval for its new automated insulin delivery system


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CarMax, Inc. (KMX) : Free Stock Analysis Report
 
Red Hat, Inc. (RHT) : Free Stock Analysis Report
 
Tandem Diabetes Care, Inc. (TNDM) : Free Stock Analysis Report
 
BlackBerry Limited (BB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research